Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magvitane
- Development stage
- Unknown
- Lead developer
- Amdis Healthsciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Magvitane is a marketed nutraceutical combination product developed by Amdis Healthsciences, an Indian pharmaceutical company. It is formulated as a combination of magnesium bisglycinate, L-methylfolate, and vitamin D3 (cholecalciferol). The product is primarily indicated for the management of magnesium deficiency and associated conditions, such as pregnancy-related leg cramps, premenstrual syndrome (PMS), and neurological support. Magnesium bisglycinate provides a highly bioavailable, chelated form of magnesium that acts as a natural calcium antagonist and NMDA receptor blocker, helping to alleviate muscle spasms. L-methylfolate is the biologically active form of folate, essential for DNA synthesis and homocysteine regulation, while vitamin D3 supports calcium absorption and immune function through the activation of the vitamin D receptor.
- Brand names
- Magvitane
- Other names
- Magnesium Bisglycinate + L-Methylfolate + Vitamin D3
02
Targets
NMDAR (Glutamate receptor ionotropic, NMDA)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Magvitane.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Magvitane.